CHINA NATIONAL MEDICINES CORPORATION LTD.

Otros idiomas China National Medicines Corporation Ltd.

Acciones

600511

CNE000001D56

Farmacéuticos

Precio de cierre Shanghai S.E. Otros sitios de cotización 15/12/2025			Variación 5 días	Varia. 1 de enero.
28,96 ^CNY	+0,10 %		-0,92 %	-15,37 %

22/10	El beneficio atribuible de China National Medicines sube un 13% en nueve meses; las acciones avanzan un 4%	MT
21/10	China National Medicines Corporation Ltd. presenta resultados financieros para los nueve meses finalizados el 30 de septiembre de 2025	CI

Otros idiomas

China National Medicines' Nine-Month Attributable Profit Jumps 13%; Shares Rise 4%	22/10
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	21/10
China National Medicines' Q3 Profit Jumps 13%	21/10
China National Medicines Q3 net profit up 13.1% Y/Y	21/10
China National Medicines' Attributable Profit Falls 5% in H1	21/08
Sinopharm Group says HY net profit attributable for China National Medicines Corp of RMB948.5 million	20/08
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	20/08
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	24/04
China National Medicines Corp Q1 Net Profit Down 0.1% Y/Y	24/04
China National Medicines' 2024 Profit Down 7%, Revenue Up 2%	20/03
China National Medicines's 2024 Net Profit Down 6.8% Y/Y	19/03
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	19/03
China National Medicines Corporation Ltd. announces Annual dividend, payable on June 18, 2025	19/03
China Stocks Slide After IMF Downgrade; China National Medicines Down 6%	24/10/24
China National Medicines' Q3 Profit Rises Marginally; Shares Fall 6%	24/10/24
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	23/10/24
China National Medicines H1 Profit Ticks Up 2%; Shares Down 4%	22/08/24
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	21/08/24
Sinopharm unit denies link to firm suspected of illegally purchasing corpses	09/08/24
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04/24
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03/24
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03/24
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03/24
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	10/01/24
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	08/12/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas China National Medicines Corporation Ltd.

Acciones

600511

CNE000001D56

Farmacéuticos

Otros idiomas

Filtros